Full text
5/2026
vol. 43
Original paper
Comprehensive evaluation of the effects of mometasone furoate combined with montelukast or loratadine on symptom control, inflammatory cytokine profiles, and T-cell subset distributions in children with co-existing asthma and allergic rhinitis
Department of Otolaryngology-Head and Neck Surgery, Taizhou People’s Hospital Affiliated to Nanjing Medical University, Taizhou, China
Adv Dermatol Allergol 2026; XLIII (5): 510-518
Data publikacji online: 2026/10/22
- Mandlik DS, Mandlik SK. New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacol Immunotoxicol 2020; 42: 521-54.
- Martin J, Townshend J, Brodlie M. Diagnosis and management of asthma in children. BMJ Paediatr Open 2022; 6: e001227.
- Matsumoto K, Kouzaki H, Yamamoto S, et al. In vitro and in vivo inhibitory effects of TLR4 agonist, glucopyranosyl lipid A (GLA), on allergic rhinitis caused by Japanese cedar pollen. Allergy 2020; 75: 446-9.
- Kou W, Li X, Yao H, Wei P. Meta-analysis of the comorbidity rate of allergic rhinitis and asthma in Chinese children. Int J Pediatr Otorhinolaryngol 2018; 107: 131-4.
- Bro¿ek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017; 140: 950-8.
- Tosca MA, Del Barba P, Licari A, Ciprandi G; Asthma And Rhinitis Control Study Group. The measurement of asthma and allergic rhinitis control in children and adolescents. Children 2007; 7: 43.
- Kuo CY, Pan RH, Chan CK, et al. Application of a time-stratified case-crossover design to explore the effects of air pollution and season on childhood asthma hospitalization in cities of differing urban patterns: big data analytics of government open data. Int J Environ Res Public Health 2018; 15: 647.
- Esmaeilzadeh H, Far NM, Nabavizadeh SH, et al. A comparative study of montelukast and azelastine add on therapy in moderate to severe allergic rhinitis treatment: a double-blind randomized clinical trial. Am J Rhinol Allergy 2022; 36: 559-67.
- Zhang Y, Wang H. Efficacy of montelukast sodium chewable tablets combined with inhaled budesonide in treating pediatric asthma and its effect on inflammatory factors. Pharmazie 2019; 74: 694-7.
- Shen C, Chen F, Wang H, et al. Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels. Braz J Otorhinolaryngol 2020; 86: 63-73.
- Zhang J, Cheng H, Luo Y, et al. Effect of loratadine tablets in combination with other drugs on nasal physiological function and T lymphocyte subsets in patients with allergic rhinitis. Comput Intell Neurosci 2022; 2022: 3990427.
- Brown T, Kruse C, Schmitt R, et al. Diagnosis and management of allergic rhinitis in children. Pediatr Ann 2019; 48: e485-8.
- Comité Nacional de Neumonología; Comité Nacional de Alergia; Comité Nacional de Emergencia y Cuidados Críticos; Comité Nacional de Familia y Salud Mental. [Guideline on diagnosis and treatment: bronchial asthma in children ≥ 6 years old. Update 2021]. Arch Argent Pediatr 2021; 119: S123-58.
- Chen ZM, Zhao DY, Xiang L, Hong JG. Treatment of pediatric mild persistent asthma with low-dose budesonide inhalation suspension vs. montelukast in China. World J Pediatr 2021; 17: 619-25.
- Song Y, Pan K, Chen Y, et al. The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials. Adv Dermatol Allergol 2021; 38: 740-5.
- Zhang J, Kan D. Evaluation of efficiency and safety of combined loratadine and budesonide in patients with anaphylactic rhinitis: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2022; 101: e28851.
- Xu Q, Lu T, Song Z, et al. Efficacy and safety of montelukast adjuvant therapy in adults with cough variant asthma: a systematic review and meta-analysis. Clin Respir J 2023; 17: 986-97.
- Krishnamoorthy M, Mohd Noor N, Mat Lazim N, Abdullah B. Efficacy of montelukast in allergic rhinitis treatment: a systematic review and meta-analysis. Drugs 2020; 80: 1831-51.
- Zhang J, Zou Y, Chen L, et al. Regulatory T cells, a viable target against airway allergic inflammatory responses in asthma. Front Immunol 2022; 13: 902318.
- Kakaje A, Alhalabi MM, Alyousbashi A, Ghareeb A. Allergic rhinitis, asthma and laryngopharyngeal reflux disease: a cross-sectional study on their reciprocal relations. Sci Rep 2021; 11: 2870.
- Hofmann MA, Fluhr JW, Ruwwe-Glösenkamp C, et al. Role of IL-17 in atopy – a systematic review. Clin Transl Allergy 2021; 11: e12047.
- Chen M, Ge Y, Lin W, et al. Clinical features and nasal inflammation in asthma and allergic rhinitis. Clin Exp Immunol 2022; 208: 25-32.
- Khaitov MR, Gaisina AR, Shilovskiy IP, et al. The role of interleukin-33 in pathogenesis of bronchial asthma. New experimental data. Biochemistry (Mosc) 2018; 83: 13-25.
- Xian M, Feng M, Dong Y, et al. Changes in CD4+CD25+FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma. Int Arch Allergy Immunol 2020; 181: 71-80.
- Jin W, Zhao Z, Zhou D. Effect of montelukast sodium combined with budesonide aerosol on airway function and T lymphocytes in asthmatic children. Pak J Med Sci 2022; 38: 1265-70.
- Bhattachan S, Neupane Y, Pradhan B, Thapa N. Comparison of outcomes between mometasone furoate intranasal spray and oral montelukast in patients with allergic rhinitis. J Nepal Health Res Counc 2020; 18: 268-70.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.